These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 35624518)

  • 1. Allergological study in patients vaccinated against COVID-19 with suspected allergic reactions.
    Jover Cerdá V; Rodríguez Pacheco R; Doménech Witek J; Alonso Hernández S; Durán García R; Real Panisello M; Marco de la Calle FM
    Allergy Asthma Clin Immunol; 2022 May; 18(1):43. PubMed ID: 35624518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of lymphocyte transformation tests (LTT) in suspected severe delayed hypersensitivity reactions following COVID-19 vaccination.
    Weir C; Sung-In Jang H; Fernando SL
    Hum Vaccin Immunother; 2023 Dec; 19(1):2182527. PubMed ID: 36912718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. COVID vaccination can be performed in patients with a history of allergic reactions to the vaccines or their components: experience from a specialist clinic in South Australia.
    Tunbridge M; Perkins G; Lee M; Salehi T; Ryoo D; Kette F; Smith W; Gold M; Le TA; Yuson C; Hissaria P
    Intern Med J; 2022 Nov; 52(11):1884-1890. PubMed ID: 35848521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of suspected and confirmed COVID-19 (SARS-CoV-2) vaccine hypersensitivity.
    Worm M; Alexiou A; Bauer A; Treudler R; Wurpts G; Dickel H; Buhl T; Müller S; Jung A; Brehler R; Fluhr J; Klimek L; Mülleneisen N; Pfützner W; Raap U; Roeseler S; Schuh S; Timmermann H; Heine G; Wedi B; Brockow K
    Allergy; 2022 Nov; 77(11):3426-3434. PubMed ID: 35722723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AstraZeneca ChAdOx1-S COVID-19 vaccine can be safely administered in patients with EDTA allergy.
    Ali SB; Perkins G; Ryoo D; Lee M; Tunbridge M; Yuson C; Smith W; Hissaria P; Le TT
    Allergy Asthma Clin Immunol; 2022 Mar; 18(1):22. PubMed ID: 35272714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SARS-CoV-2 and allergy - what have we learned after two and a half years?
    Brockow K; Wang R; Mathes S; Bent R; Faihs V; Eberlein B; Darsow U; Biedermann T
    Allergol Select; 2023; 7():101-112. PubMed ID: 37056446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of pediatric patients with suspected polyethylene glycol and polysorbate allergy before mRNA SARS-CoV2 vaccination.
    Karaaslan BG; Burtecene N; Mustu U; Ocak S; Kasapcopur O; Kıykım A; Cokugras H
    Allergol Immunopathol (Madr); 2023; 51(3):174-180. PubMed ID: 37169575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypersensitivity reactions to anti-SARS-CoV-2 vaccines: Basophil reactivity to excipients.
    Pignatti P; Ramirez GA; Russo M; Marraccini P; Nannipieri S; Asperti C; Torre FD; Tiri A; Gatti BM; Gurrado A; Meriggi A; Benanti G; Cilona MB; Pigatto P; Burastero SE; Dagna L; Yacoub MR
    Vaccine; 2023 Jul; 41(32):4693-4699. PubMed ID: 37349223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.
    Akova M; Unal S
    Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. First-Dose mRNA COVID-19 Vaccine Allergic Reactions: Limited Role for Excipient Skin Testing.
    Wolfson AR; Robinson LB; Li L; McMahon AE; Cogan AS; Fu X; Wickner P; Samarakoon U; Saff RR; Blumenthal KG; Banerji A
    J Allergy Clin Immunol Pract; 2021 Sep; 9(9):3308-3320.e3. PubMed ID: 34166844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Basophil Activation Test with Different Polyethylene Glycols in Patients with Suspected PEG Hypersensitivity Reactions.
    Vespa S; Del Biondo P; Simeone P; Cavallucci E; Catitti G; Auciello R; De Bellis D; Altomare I; Pierdomenico L; Canonico B; Cicalini I; Angilletta I; Del Boccio P; Pieragostino D; Santilli F; Urbani A; De Laurenzi V; Stuppia L; Lanuti P
    Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36498922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intradermal Testing With COVID-19 mRNA Vaccines Predicts Tolerance.
    Stehlin F; Mahdi-Aljedani R; Canton L; Monzambani-Banderet V; Miauton A; Girard C; Kammermann K; Meylan S; Ribi C; Harr T; Yerly D; Muller YD
    Front Allergy; 2022; 3():818049. PubMed ID: 36238929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frequency of allergic reactions in egg allergic patients after receiving the yellow fever vaccine.
    García-Paba MB; Aparicio C; Rodríguez M; Moreno S; García E
    Allergol Immunopathol (Madr); 2023; 51(4):139-147. PubMed ID: 37422790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of Second Allergic Reaction to SARS-CoV-2 Vaccines: A Systematic Review and Meta-analysis.
    Chu DK; Abrams EM; Golden DBK; Blumenthal KG; Wolfson AR; Stone CA; Krantz MS; Shaker M; Greenhawt M
    JAMA Intern Med; 2022 Apr; 182(4):376-385. PubMed ID: 35188528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The value of the basophil activation test in the evaluation of patients reporting allergic reactions to the BNT162b2 mRNA COVID-19 vaccine.
    Labella M; Céspedes JA; Doña I; Shamji MH; Agache I; Mayorga C; Torres MJ
    Allergy; 2022 Jul; 77(7):2067-2079. PubMed ID: 34689351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Vaccination approach in patients with an allergic reaction to COVID-19 vaccines or at risk of developing allergic reactions].
    Özden Ş; Tepetam FM; Atik Ö
    Tuberk Toraks; 2023 Jun; 71(2):166-175. PubMed ID: 37345399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic accuracy of vaccine and vaccine excipient testing in the setting of allergic reactions to COVID-19 vaccines: A systematic review and meta-analysis.
    Greenhawt M; Shaker M; Golden DBK; Abrams EM; Blumenthal KG; Wolfson AR; Stone CA; Krantz MS; Chu DK; Dwamena BA
    Allergy; 2023 Jan; 78(1):71-83. PubMed ID: 36321821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characteristics of immune response profile in patients with immediate allergic and autoimmune urticarial reactions induced by SARS-CoV-2 vaccines.
    Wang CW; Chen CB; Lu CW; Chen WT; Hui RC; Chiu TM; Chi MH; Lin JC; Huang YH; Chang YC; Wu J; Chen KY; Lin YY; Ger TY; Lin JY; Tsai WT; Pan YJ; Chung WH
    J Autoimmun; 2023 Jul; 138():103054. PubMed ID: 37245259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protocol of safe vaccination against COVID-19 in patients with high risk of allergic reactions.
    Romantowski J; Kruszewski J; Solarski O; Bant A; Chciałowski A; Pietrzyk I; Sańpruch P; Górska A; Chełmińska M; Knurowska A; Gawinowska M; Jassem E; Niedoszytko M
    Clin Transl Allergy; 2022 May; 12(5):e12152. PubMed ID: 35601631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Study of Excipients in Delayed Skin Reactions to mRNA Vaccines: Positive Delayed Intradermal Reactions to Polyethylene Glycol Provide New Insights for COVID-19 Arm.
    Pesqué D; Pujol RM; Marcantonio O; Vidal-Navarro A; Ramada JM; Arderiu-Formentí A; Albalat-Torres A; Serra C; Giménez-Arnau AM
    Vaccines (Basel); 2022 Nov; 10(12):. PubMed ID: 36560458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.